Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is characterized by the presence of the BCR-ABL1 fusion gene. In more than 95% of CML patients, the typical BCR-ABL1 transcript subtypes are e13a2 (b2a2), e14a2 (b3a2), or the simultaneous expression of both. Other less frequent transcript subtypes, such as e1a2, e2a2...
Main Authors: | matteo molica, elisabetta abruzzese, massimo breccia |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2020-08-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | https://www.mjhid.org/index.php/mjhid/article/view/4280 |
Similar Items
-
Molecular responses in e19a2 BCR-ABL1 chronic myeloid leukemia
by: Laura Kearney, et al.
Published: (2020-01-01) -
Treatment free remission in chronic myeloid leukemia: Lights and shadows
by: Matteo Molica, et al.
Published: (2020-09-01) -
Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
by: Vlad Moisoiu, et al.
Published: (2019-09-01) -
A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review
by: Monica Piedimonte, et al.
Published: (2019-01-01) -
Clinical and Psychological Factors to Consider in Achieving Treatment-Free Remission in Patients With Chronic Myeloid Leukemia
by: Massimo Breccia, et al.
Published: (2021-03-01)